About ENDS US

The e-cigarette industry is currently a $5.4 billion dollar industry, according to the Smoke-Free Alternative Trade Association.  Projected to grow into a $50 billion market by 2025, e-cigarettes have exploded in growth and popularity since they were invented in 2003. 

As they have grown in popularity, the number and variety of e-cigarette flavors and fragrances has expanded to include more than 7700 available flavors, with hundreds more added each month.  As of 2014, nearly 500 brands of e-cigarettes were being sold and the market was largely unregulated.  

With such a large and growing industry, the United States Food and Drug Administration and the European Commission announced rules governing the treatment of e-cigarettes and how they will be regulated.

In May 2016 in the United States, the Food and Drug Administration announced 'deeming rules' extending the agency's authority to regulate to e-cigarettes. Among other provisions, these regulations stated that e-cigarette products could not be purchased by those under 18, free samples were barred, and certain advertising claims (including "light" or "mild" to describe products) were disallowed. Over the longer term, manufacturers must, again among other things, submit ingredient lists for each product and pursue either substantial equivalency or pre-market tobacco applications for products introduced after February 15, 2007. 

Understanding how to operate as a business within this complex web of changing regulations inspired Smithers Rapra to launch this conference. With a successful track record of delivering high quality regulatory events, specifically the Extractables and Leachables Conference and Global Food Contact, Smithers Rapra can help you to find a path forward in these confusing times.

Working directly with industry experts, the program for this year's event will help you expand knowledge on topics such as:

  • Current and emerging regulations for e-cigarettes, including  USA FDA Deeming Regulations and European Commission Tobacco Products Directive;
  • Legal standards and compliance concerns; 
  • Testing standards and submission processes and protocols;
  • Other regulatory perspectives, including USA states, Canada, and the rest of the world;
  • And much more.

Find out more about ENDS US here.